Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 20 October 2019 doi:10.20944/preprints201910.0239.v1 Construction of a neuro-immune-cognitive pathway-phenotype underpinning the phenome of deficit schizophrenia. Hussein Kadhem Al-Hakeima, Abbas F. Almullab, Arafat Hussein Al-Dujailic, Michael Maes d,e,f. a Department of Chemistry, College of Science, University of Kufa, Iraq. E-mail:
[email protected]. b Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq. E-mail:
[email protected]. c Senior Clinical Psychiatrist, Faculty of Medicine, Kufa University. E-mail:
[email protected]. d* Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; e Department of Psychiatry, Medical University of Plovdiv, Plovdiv, Bulgaria; f IMPACT Strategic Research Centre, Deakin University, PO Box 281, Geelong, VIC, 3220, Australia. Corresponding author Prof. Dr. Michael Maes, M.D., Ph.D. Department of Psychiatry Faculty of Medicine Chulalongkorn University Bangkok Thailand 1 © 2019 by the author(s). Distributed under a Creative Commons CC BY license. Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 20 October 2019 doi:10.20944/preprints201910.0239.v1 https://scholar.google.co.th/citations?user=1wzMZ7UAAAAJ&hl=th&oi=ao
[email protected]. 2 Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 20 October 2019 doi:10.20944/preprints201910.0239.v1 Abstract In schizophrenia, pathway-genotypes may be constructed by combining interrelated immune biomarkers with changes in specific neurocognitive functions that represent aberrations in brain neuronal circuits. These constructs provide insight on the phenome of schizophrenia and show how pathway-phenotypes mediate the effects of genome X environmentome interactions on the symptomatology/phenomenology of schizophrenia.